Stocksigma LogoStocksigma Logo

Glenmark Pharmaceuticals Schedules Board Meeting for Q2 FY27 Results

Glenmark Pharmaceuticals Limited will hold a Board of Directors meeting on 5th Nov'26 to consider and approve its standalone and consolidated unaudited

Glenmark Pharmaceuticals Schedules Board Meeting for Q2 FY27 Results

Glenmark Pharmaceuticals Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

Glenmark Pharmaceuticals Schedules Board Meeting for Q2 FY27 Results Glenmark Pharmaceuticals Limited will hold a Board of Directors meeting on 5th Nov'26 to consider and approve its standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Consequently, the trading window for designated persons and insiders, which closed on 1st Oct'26, will remain shut until 7th Nov'26 and reopen on 8th Nov'26, in compliance with SEBI insider trading regulations.

Original exchange filing (PDF)

More announcements from Glenmark Pharmaceuticals Ltd

All Glenmark Pharmaceuticals Ltd announcements